|

Low-dose psilocybin Clinical Trials

1 actively recruiting trial across 1 location

Also known as: low-dose COMP360

Pipeline

Phase 2: 1

Top Sponsors

  • University of Texas at Austin1

Indications

  • Recurrent Depression1
  • Treatment-resistant Depression1
  • Major Depressive Disorder1
  • MDD1
  • Depression1

Austin, Texas1 trial

Psilocybin rTMS for Treatment Resistant Depression

Health Discovery Building (HDB), 1601 Trinity St., Bldg B., Z0600

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.